762 Prognostic and Predictive Value of TP53 Mutations in Node-positive Breast Cancer Patients Treated with Anthracycline-or Anthracycline/taxane Based Adjuvant Therapy – Results From the BIG 02-98 Phase III Trial

✍ Scribed by M. Olivier; L. Fernández-Cuesta; C. Oakman; E. Quinaux; M.S. Dolci; P.A. Francis; M. Piccart-Gebhart; G. Viale; A. DiLeo

• Book ID: 117663231
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 71 KB
• Volume: 48
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(12)71398-9